{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-030145","form_type":"8-K","ticker":"CTOR","cik":"0001851484","company_name":"CITIUS ONCOLOGY, INC.","filed_at":"2024-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.920818+00:00","generated_at":"2026-05-31T13:13:59.397599+00:00","sec_items":["5.02","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"TenX Keane shareholders approve business combination with Citius Oncology; redemptions total $49.3M","bullets":["All eight proposals approved, including business combination, domestication to Delaware, name change to Citius Oncology, and 15M-share stock incentive plan.","4,297,828 shares redeemed at ~$11.46 per share, aggregating $49,265,965 from trust account.","Eight directors elected to staggered terms: Myron Holubiak, Joel Mayersohn, Dr. Eugene Holuka, Robert Smith, Carol Webb, Suren Dutia, Leonard Mazur, Dennis McGrath.","Business combination involves Citius Oncology (spin-off from Citius Pharma) merging into TenX; closing conditions still pending.","Incentive plan authorizes options, SARs, restricted stock, RSUs, and cash awards for employees, directors, and consultants."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-030145","json":"https://secwatch.observer/filing/0001493152-24-030145.json","markdown":"https://secwatch.observer/filing/0001493152-24-030145.md","text":"https://secwatch.observer/filing/0001493152-24-030145.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1851484/000149315224030145/0001493152-24-030145-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1851484/000149315224030145/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:13:59.397599+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}